Radiopharmaceutical product for the treatment of cancer; radiopharmaceutical compounds for the treatment of neuroendocrine tumors; pharmaceutical preparations for the treatment of somatostatin receptor-positive neuroendocrine tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders.
FORMALIZED
on 28 Feb 2024
BRAVNETSA
LANTHEUS MEDICAL IMAGING INC.
2312957 · 10 Jan 2024
005
Class 005
Pharmaceutical Products
Radiopharmaceutical product for the treatment of cancer; radiopharmaceutical compounds for the treatment of neuroendocrine tumors; pharmaceutical preparations for the treatment of somatostatin receptor-positive neuroendocrine tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders.
Radiopharmaceutical product for the treatment of cancer; radiopharmace...
